Endoxifen: The End, or Are We at the Beginning?
Author:
Affiliation:
1. V. Craig Jordan, University of Texas MD Anderson Cancer Center, Houston, TX
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2017.74.9325
Reference30 articles.
1. Tamoxifen: a most unlikely pioneering medicine
2. Tamoxifen: Catalyst for the change to targeted therapy
3. Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer
4. Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
5. Raloxifene, in Taylor JB, Triggle DJ (eds): Comprehensive Medicinal Chemistry II. Oxford, United Kingdom, Elsvier, 2007, pp 103-121 doi:10.1016/B0-08-045044-X/00294-7
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Solanidine Metabolites as Diet‐Derived Biomarkers of CYP2D6‐Mediated Tamoxifen Metabolism in Breast Cancer Patients;Clinical Pharmacology & Therapeutics;2024-07-22
2. Personalizing tamoxifen therapy in adjuvant therapy: a brief summary of the ongoing discussion;Expert Review of Clinical Pharmacology;2022-12-06
3. Combination of structure-performance and shape-performance relationships for better biphasic release in electrospun Janus fibers;International Journal of Pharmaceutics;2021-03
4. The First Targeted Therapy to Treat Cancer: The Tamoxifen Tale;Estrogen Receptor and Breast Cancer;2018-10-17
5. Clinical Potential of Estrogen and Progesterone Receptor Imaging;PET Clinics;2018-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3